ESR1 and breast carcinoma: Although progresses have been made in breast cancer, the huge threat of this cancer for women is still serious, and particularly the patients who suffer from the ‘triple-negative’ breast cancer (TNBC), which is negative for the expressions of progesterone (PR), estrogen receptors (ER) and HER2 [3–5].